Bachem Holding AG (SWX:BANB)
Switzerland · Delayed Price · Currency is CHF 83.15
-1.00 (-1.19%)
Oct 22, 2026, 10:34 AM CEST
Bachem Holding AG Market Cap
Bachem Holding AG has a market cap or net worth of 6.23 billion as of October 21, 2026. It is the 2,628th most valuable company in the world and the 42nd biggest in Switzerland. Its market cap has increased by 51.66% in one year.
Market Cap
6.23B
Enterprise Value
6.39B
Revenue
708.53M
Global Rank
Country Rank
#42 Switzerland
PE Ratio
41.91
ChartMarket Cap Chart
Since March 1, 1999, Bachem Holding AG's market cap has increased from 1.52B to 6.23B, an increase of 309.14%. That is a compound annual growth rate of 5.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 6.44B | 43.50% |
| Dec 30, 2025 | 4.49B | 3.45% |
| Dec 30, 2024 | 4.34B | -10.92% |
| Dec 29, 2023 | 4.87B | -17.25% |
| Dec 30, 2022 | 5.89B | -44.23% |
| Dec 30, 2021 | 10.56B | 90.80% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 1.15B |
| Basilea Pharmaceutica AG | 849.56M |
| Santhera Pharmaceuticals Holding AG | 226.77M |
| Newron Pharmaceuticals | 180.53M |
| BioVersys AG | 145.46M |
| Molecular Partners AG | 116.45M |
| Xlife Sciences AG | 53.98M |
| MindMaze Therapeutics Holding | 26.25M |